BMC Pulmonary Medicine

unofficial impact factor 1.91

Open Access Research article

Long acting β2 agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trials

Don Husereau1*, Vijay Shukla1, Michel Boucher1, Shaila Mensinkai1 and Robert Dales2

  • * Corresponding author: Don Husereau donh@ccohta.ca

  • † Equal contributors

Author Affiliations

1 Canadian Coordinating Office for Health Technology Assessment (CCOHTA), 600-865 Carling Avenue, Ottawa ON K1S 5S8, Canada

2 Health Research Institute, University of Ottawa, Ottawa ON K1H 8L6, Canada

For all author emails, please log on.

BMC Pulmonary Medicine 2004, 4:7 doi:10.1186/1471-2466-4-7

Published: 31 August 2004

Additional files

Additional File 1:

Appendix 1. A list of reports considered in this review but excluded.

Format: PDF Size: 143KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data

Additional File 2:

Appendix 2. Search strategies including databases, time horizons and subject headings/keywords used to locate trials.

Format: PDF Size: 52KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data